Stock Price
4.48
Daily Change
0.06 1.36%
Monthly
13.42%
Yearly
92.27%
Q1 Forecast
4.10

Acasti Pharma reported $459K in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
Acasti Pharma USD 459K 881K Sep/2025
Addus HomeCare USD 16.83M 155K Dec/2025
Amarin USD 36.71M 8M Sep/2025
Cassava Sciences USD 46.09M 3.27M Sep/2025
Knight Therapeutics CAD 118.13M 8.16M Sep/2025
Option Care Health USD 639.83M 11.96M Dec/2025
Organigram Holdings CAD 89.25M 556K Sep/2025
Tilray USD 107.35M 8.43M Mar/2025